Heterogeneity of metalloproteinase expression in colorectal cancer - Relation of molecular findings to basic morphology

Anticancer Research

Volumn 31, Issue 5, 2011, Pages 1567-1575

  Kajiwara, Yoshiki ^a   Ueno, Hideki ^a   Hashiguchi, Yojiro ^a   Shinto, Eiji ^a   Shimazaki, Hideyuki ^a   Mochizuki, Hidetaka ^a   Hase, Kazuo ^a  

^a NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

Author keywords

ADAM; Colorectal cancer; Invasive front; MMP; Solid cancer nest; TIMP

Indexed keywords

ADAM PROTEIN; ADAM10 ENDOPEPTIDASE; GELATINASE A; GELATINASE B; INTERSTITIAL COLLAGENASE; MATRILYSIN; MATRIX METALLOPROTEINASE; MESSENGER RNA; STROMELYSIN; TISSUE INHIBITOR OF METALLOPROTEINASE; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2; TISSUE INHIBITOR OF METALLOPROTEINASE 3; TISSUE INHIBITOR OF METALLOPROTEINASE 4; TUMOR NECROSIS FACTOR ALPHA CONVERTING ENZYME;

ADULT; AGED; ARTICLE; CANCER CELL; CANCER INVASION; CANCER SURGERY; CLINICAL ARTICLE; COLORECTAL CANCER; CONTROLLED STUDY; FEMALE; HUMAN; LASER MICRODISSECTION; MALE; PRIMARY TUMOR; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN POLYMORPHISM; UPREGULATION;

ADAM PROTEINS; AGED; AGED, 80 AND OVER; COLORECTAL NEOPLASMS; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; MATRIX METALLOPROTEINASES; MEMBRANE PROTEINS; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PROGNOSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SURVIVAL RATE; UP-REGULATION;

EID: 79958170449     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Gabbert H: Mechanism of tumor invasion: Evidence from in vivo observations. Cancer Metastasis Rev 4: 293-309, 1985.
2. Hase K, Shatney C, Johnson D, Trollope M and Vierra M: Prognostic value of tumor 'budding' in patients with colorectal cancer. Dis Colon Rectum 36: 627-635, 1993.
3. Ueno H, Murphy J, Jass JR, Mochizuki H and Talbot IC: Tumor 'budding' as an index to estimate the potential of aggressiveness in rectal cancer. Histopathology 40: 127-132, 2002.
4. Ueno H, Mochizuki H, Hashiguchi Y, Ishiguro M, Miyoshi M, Kajiwara Y, Sato T, Shimazaki H, Hase K and Talbot IC: Histological grading of colorectal cancer a simple and objective method. Ann Surg 247: 811-818, 2008. (Pubitemid 351591516)
5. Liotta LA, Steeg PS and Stetler-Stevenson WG: Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation. Cell 64: 327-336, 1991. (Pubitemid 121001258)
6. Egeblad M and Werb Z: New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer 2: 161-174, 2002. (Pubitemid 37328786)
7. Mochizuki S and Okada Y: ADAMs in cancer cell proliferation and progression. Cancer Sci 98: 621-628, 2007. (Pubitemid 46563436)
8. Arribas J, Bech-Serra JJ and Santiago-Josefat B: ADAMs, cell migration and cancer. Cancer Metastasis Rev 25: 57-68, 2006.
9. The Japanese society for cancer of the colon and rectum: Japanese classification of colorectal carcinoma, first English editrion. Tokyo: Kanehara & Co. Ltd., 1997.
10. Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, De Paepe A and Speleman F: Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol 3: RESEARCH0034, 2002.
11. Poulsom R, Pignatelli M, Stetler-Stevenson WG, Liotta LA, Wright PA, Jeffery RE, Longcroft JM, Rogers L and Stamp GW: Stromal expression of 72 kDa type IV collagenase (MMP-2) and TIMP-2 mRNAs in colorectal neoplasia. Am J Pathol 141: 389-396, 1992.
12. Zeng ZS and Guillem JG: Distinct pattern of matrix metalloproteinase 9 and tissue inhibitor of metalloproteinase 1 mRNA expression in human colorectal cancer and liver metastases. Br J Cancer 72: 575-582, 1995.
13. Tomita T and Iwata K: Matrix metalloproteinases and tissue inhibitors of metalloproteinases in colonic adenomas-adenocarcinomas. Dis Colon Rectum 39: 1255-1264, 1996. (Pubitemid 26389536)
14. Zeng ZS and Guillem JG: Colocalisation of matrix metalloproteinase-9-mRNA and protein in human colorectal cancer stromal cells. Br J Cancer 74: 1161-1167, 1996. (Pubitemid 26360102)
15. Holten-Andersen MN, Hansen U, Brunner N, Nielsen HJ, Illemann M and Nielsen BS: Localization of tissue inhibitor of metalloproteinases 1 (TIMP-1) in human colorectal adenoma and adenocarcinoma. Int J Cancer 113: 198-206, 2005. (Pubitemid 39628309)
16. Wilson CL and Matrisian LM: Matrilysin: an epithelial matrix metalloproteinase with potentially novel functions. Int J Biochem Cell Biol 28: 123-136, 1996. (Pubitemid 26072499)
17. Adachi Y, Yamamoto H, Itoh F, Arimura Y, Nishi M, Endo T and Imai K: Clinicopathologic and prognostic significance of matrilysin expression at the invasive front in human colorectal cancers. Int J Cancer 95: 290-294, 2001. (Pubitemid 32847038)
18. Kahlert C, Bandapalli OR, Schirmacher P, Weitz J and Brand K: Invasion front-specific overexpression of tissue inhibitor of metalloproteinase-1 in liver metastases from colorectal cancer. Anticancer Res 28: 1459-1465, 2008. (Pubitemid 351892917)
19. Knosel T, Emde A, Schluns K, Chen Y, Jurchott K, Krause M, Dietel M and Petersen I: Immunoprofiles of 11 biomarkers using tissue microarrays identify prognostic subgroups in colorectal cancer. Neoplasia 7: 741-747, 2005.
20. Gavert N, Conacci-Sorrell M, Gast D, Schneider A, Altevogt P, Brabletz T and Ben-Ze'ev A: L1, a novel target of beta-catenin signaling, transforms cells and is expressed at the invasive front of colon cancers. J Cell Biol 168: 633-642, 2005.
21. Merchant NB, Voskresensky I, Rogers CM, Lafleur B, Dempsey PJ, Graves-Deal R, Revetta F, Foutch AC, Rothenberg ML, Washington MK and Coffey RJ: TACE/ADAM-17: a component of the epidermal growth factor receptor axis and a promising therapeutic target in colorectal cancer. Clin Cancer Res 14: 1182-1191, 2008. (Pubitemid 351302567)
22. Blanchot-Jossic F, Jarry A, Masson D, Bach-Ngohou K, Paineau J, Denis MG, Laboisse CL and Mosnier JF: Up-regulated expression of ADAM17 in human colon carcinoma: coexpression with EGFR in neoplastic and endothelial cells. J Pathol 207: 156-163, 2005. (Pubitemid 41404146)
23. Iba K, Albrechtsen R, Gilpin BI, Loechel F and Wewer UM: Cysteine-rich domain of human ADAM 12 (meltrin alpha) supports tumor cell adhesion. Am J Pathol 154: 1489-1501, 1999. (Pubitemid 29226444)
24. Le Pabic H, Bonnier D, Wewer UM, Coutand A, Musso O, Baffet G, Clement B and Theret N: ADAM12 in human liver cancers: TGF-beta-regulated expression in stellate cells is associated with matrix remodeling. Hepatology 37: 1056-1066, 2003. (Pubitemid 36538682)
25. Kveiborg M, Frohlich C, Albrechtsen R, Tischler V, Dietrich N, Hoick P, Kronqvist P, Rank F, Mercurio AM and Wewer UM: A role for ADAM 12 in breast tumor progression and stromal cell apoptosis. Cancer Res 65: 4754-4761, 2005. (Pubitemid 40740812)
26. Frohlich C, Albrechtsen R, Dyrskjot L, Rudkjaer L, Orntoft TF and Wewer UM: Molecular profiling of ADAM12 in human bladder cancer. Clin Cancer Res 12: 7359-7368, 2006. (Pubitemid 46095409)